プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Gregory W.に依頼

United Kingdom

Cancer cell biologist 20+ years of experience

プロフィール概要

Development of new on demand diagnostic methods in field of cancer cell biology utilising imaging techniques, molecular biology, protein modifications. Transfer of knowledge, hand to hand training. Automation specialist.

専門分野

• ★ In vitro Diagnostic Design
• ★ Biomarker Analysis
• ★ Cancer Research
• ☆ In vitro Diagnostics
• ☆ In vitro Diagnostic Validation
• ☆ Point-of-Care Devices
• ☆ Lab-on-a-Chip Devices
• ☆ Cancer Biology

サービス

• Research
• Consulting
• Product Development

Research User Research, Technology Scouting, Fact Checking, Gap Analysis

Consulting Operations Consulting

Product Development Product Evaluation, Product Validation

職務経験

Consultant Senior Scientist, assay development

King's College London

4月 2007 - 現在

Research Fellow

King's College London

4月 2007 - 現在

学歴

Ph.D

Tel-Aviv University

9月 1998 - 8月 2004

認定資格

• Ph.D. Degree

  Tel-Aviv University

  8月 2004 - 現在

出版物

JOURNAL ARTICLE

Gregory Weitsman, Valentí Gómez, Myria Galazi, James Monypenny, Fahad Al-Salemee, Paul R. Barber, Kenrick Ng, Richard Beatson, Bálint Szokol, László Orfi, et al. (2022). HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models . Molecular Cancer Therapeutics.

Gregory Weitsman, Robin Bofinger, Rachel Evans, Matthias Glaser, Kerstin Sander, Helen Allan, Daniel Hochhauser, Tammy L. Kalber, Erik Årstad, Helen C. Hailes, et al.(2021). Drug delivery, biodistribution and anti-EGFR activity: theragnostic nanoparticles for simultaneous in vivo delivery of tyrosine kinase inhibitors and kinase activity biosensors . Nanoscale. Royal Society of Chemistry ({RSC})